The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

Highmark cited exorbitant drug costs, higher medical utilization and sicker patients remaining in its Medicaid business for fueling fiscal pressures.

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...

A typical CGM detects glucose levels in the interstitial fluid with an enzyme-based sensor. The sensor converts glucose ...

According to nutritionist Ángela Quintas it all comes down to what you’re eating—and, more specifically, how it impacts your ...

Maintaining stable blood sugar levels is necessary for health and well-being. Medical practitioners have advised each ...

Dr. Troy Mensen is a family medicine doctor based in the Chicago area. He completed his undergraduate degree at the University of Northern Iowa and his doctorate at Des Moines University College ...

If you've been on the internet at all over the last few months, you've more than likely heard of the drug Ozempic.

Discover how reheated rice supports digestion, promotes satiety, and aids weight management through its resistant starch ...